Rabbit monoclonal antibody (RabMAb) demonstrates larger sensitivity with out sacrificing specificity than mouse monoclonal antibody (MMAb). MMAb towards E-cadherin stain is closely utilized in distinguishing ductal carcinoma in situ (DCIS) from lobular carcinoma in situ (LCIS). We aimed to check the E-cadherin stain utilizing RabMAb vs MMAb in distinguishing DCIS from LCIS.
One hundred and seventeen in situ breast carcinomas (55 DCIS, 58 LCIS, and four DCIS and LCIS) have been studied. Sections from a consultant block of every have been stained with RabMAb [EP700Y] and MMAb [36B5]. Scanned photos of stained slides have been in contrast in tandem.
All DCIS instances (59/59) confirmed comparable staining by RabMAb and MMAb. Comparable staining was additionally noticed in all however one case of LCIS (61/62; 98%).
One case of pleomorphic LCIS confirmed principally full, weak to reasonably intense membranous staining with RabMAb and fragmented, weak membranous staining with MMAb.
NFAT Inhibitor |
A4539-5 |
ApexBio |
5 mg |
EUR 540 |
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells. |
NFAT Inhibitor |
H-4874.0500 |
Bachem |
0.5mg |
EUR 327.6 |
Description: Sum Formula: C75H118N20O22S; CAS# [249537-73-3] net |
NFAT Inhibitor |
H-4874.1000 |
Bachem |
1.0mg |
EUR 544.8 |
Description: Sum Formula: C75H118N20O22S; CAS# [249537-73-3] net |
Antibiotic NFAT 133 |
T125647-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
NFAT activation molecule 1 |
AP85978 |
SAB |
1mg |
EUR 2640 |
|
NFAT activation molecule 1 |
AP86130 |
SAB |
1mg |
EUR 2640 |
|
NFAT eGFP Reporter Lentivirus |
79922 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The NFAT eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced GFP gene driven by the NFAT response element located upstream of the minimal TATA promoter. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by examining eGFP expression._x000D_ |
Jurkat-Lucia™ NFAT Cells |
jktl-nfat |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1289.4 |
Human NFAT Reporter Cell Line |
ABC-RC0113 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Reporter Cell Line can be used as follows: • Monitor intracellular calcium levels. • Screen for activators or inhibitors of PKC/ Ca2+ pathway. • Screen for agonists or antagonists of T cell receptors. • Control for immune checkpoint NFAT reporter cell lines. |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT Transcription Factor Regulator-1 |
HY-112778 |
MedChemExpress |
100mg |
EUR 3847.2 |
NFAT Transcription Factor Regulator-1 |
T12218-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Luciferase-RFP Reporter Lentivirus |
78617-H |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-RFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and RFP (Red Fluorescent Protein) cassette driven by the NFAT response element located upstream of the minimal TATA promoter and a hygromycin or puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or RFP expression. RFP fluoresces red-orange when excited; it has an excitation wavelength of 553 nm, and an emission wavelength of 574 nm. |
NFAT Luciferase-RFP Reporter Lentivirus |
78617-P |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-RFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and RFP (Red Fluorescent Protein) cassette driven by the NFAT response element located upstream of the minimal TATA promoter and a hygromycin or puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or RFP expression. RFP fluoresces red-orange when excited; it has an excitation wavelength of 553 nm, and an emission wavelength of 574 nm. |
NFAT-GFP Stable HeLa Cell Line |
T6484 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
NFAT Reporter (Luc) - Jurkat Cell Line |
60621 |
BPS Bioscience |
2 vials |
EUR 2295 |
Description: The NFAT Reporter - Jurkat Cell Line contains a firefly luciferase gene under the control of the_x000D_NFAT response element stably integrated into Jurkat cells. This cell line has been validated for_x000D_response to thapsigargin, ionomycin, and phorbol 12-myristate 13-acetate (PMA). It is useful as_x000D_a control cell line for other NFAT reporter cell lines expressing various immune checkpoint_x000D_receptors. |
ICOS/NFAT Report Cell Line--Jurkat |
ABC-RC093D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of a chimeric receptor consisting human ICOS (also known as inducible T-cell costimulator or CD278, Genbank Accession #NM_012092) and the cytoplasmic domain of human CD3 zeta. |
VEGFR2/NFAT Report Cell Line- HEK293 |
ABC-RC102D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant HEK-293 cells expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human VEGFR2 (Human Vascular Endothelial Growth Factor Receptor 2; KDR, FLK1; ref seq. NM_002253.1). |
LAG3/NFAT Report Cell Line-Jurkat |
ABC-RC110D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human LAG3 (lymphocyte-activation gene 3, CD223, GenBank Accession # NM_002286). |
Jurkat-Lucia™ NFAT-CD16 Cells |
jktl-nfat-cd16 |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
Jurkat-Lucia™ NFAT-CD28 Cells |
jktl-nfat-cd28 |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
Jurkat-Lucia™ NFAT-CD32 Cells |
jktl-nfat-cd32 |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
TIGIT / NFAT Reporter - Jurkat Cell Line |
60538 |
BPS Bioscience |
2 vials |
EUR 10855 |
Description: Recombinant Jurkat cell line constitutively expressing a full length human TIGIT (T_x000D_cell Immunoreceptor with Immunoglobulin and ITIM domain; VSTM3), and a firefly luciferase_x000D_gene under the control of nuclear factor of activator T cells (NFAT) response element. Both_x000D_TIGIT and NFAT constructs have been stably integrated into Jurkat cells. TIGIT expression has_x000D_been confirmed by Western Blot, and TIGIT-specific NFAT response has been validated using a_x000D_TIGIT ligand, CD155 (PVR). |
Human NFAT Reporter Cell Line– HEK293 |
ABC-RC0111 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Reporter Cell Line is derived from HEK293. This reporter cell line is an ideal product to monitor the blogical ativity |
Human NFAT Reporter Cell Line–RAW264.7 |
ABC-RC0112 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Reporter Cell Line is derived from RAW264.7. This reporter cell line is an ideal product to monitor the blogical ativity |
TIGIT/NFAT Report Cell Line-Jurkat |
ABC-RC112D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human TIGIT (V-set and immunoglobulin domain-containing protein 9, VSIG9, V-set and transmembrane domain-containing protein 3, and VSTM3, GenBank Accession No. NM_173799). |
pGreenFire 2.0 NFAT reporter virus (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro) |
TR451VA-P |
SBI |
>2 x 10^6 IFUs |
EUR 702 |
NFAT-Luciferase Stable RAW264.7 Cell Line |
T6125 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
pGreenFire 2.0 NFAT reporter plasmid (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro) |
TR451PA-P |
SBI |
10 µg |
EUR 702 |
NFAT Luciferase Reporter Lentivirus-79579-G |
79579-G |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (hygromycin, puromycin, or G418) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Luciferase Reporter Lentivirus-79579-H |
79579-H |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter and an antibiotic selection gene (hygromycin or puromycin) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Luciferase Reporter Lentivirus-79579-P |
79579-P |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter and an antibiotic selection gene (hygromycin or puromycin) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
PD-1 / NFAT Reporter - Jurkat Cell Line |
60535 |
BPS Bioscience |
2 vials |
EUR 11375 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_005018)._x000D_ |
Jurkat-Lucia™ NFAT-CD16-Low Cells |
jktl-nfat-cd16lo |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
NFAT Reporter (Luciferase) - THP-1 Cell Line |
78320 |
BPS Bioscience |
2 vials |
EUR 1810 |
Description: The NFAT reporter (Luciferase)-THP-1 cell line is designed for monitoring the NFAT (nuclear factor of activated T-cells) signaling pathway in THP-1 cells by measuring luciferase activity. It contains a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter. Upon activation by NFAT activators such as Ionomycin, endogenous NFAT transcription factors bind to the DNA response elements, inducing transcription of the luciferase reporter gene. |
Mouse NFAT activation molecule 1 ELISA Kit |
EK4618 |
SAB |
96 tests |
EUR 659 |
|
Human NFAT Luciferase Reporter Cell Line- HeLa |
ABC-RC0023 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Luciferase Reporter Cell Line- HeLa is derived from human cervical cancer, and stably express firefly luciferase reporter gene under the control of NFAT response element. This cell line is an ideal cellular model for monitoring the activation of Calcium Signaling Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
BTLA/NFAT - Luciferase Report Cell Line-Jurkat |
ABC-RC100D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human BTLA (B and T lymphocyte associated, B and T lymphocyte attenuator, BTLA1, CD272, GenBank Accession #NM_181780). |
NFAT Reporter (eGFP) Jurkat Recombinant Cell Line |
78384 |
BPS Bioscience |
2 vials |
EUR 2240 |
Description: Recombinant Jurkat T-cells expressing an enhanced GFP (eGFP) gene under the control of NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway can be monitored by examining eGFP expression. |
CD160/NFAT - Luciferase Report Cell Line-Jurkat |
ABC-RC096D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human CD160. CD160 is a GPIanchored glycoprotein member of the Ig superfamily, also known as BY55, NK1, and NK28. GenBank Accession # NM_007053. |
TMIGD2/NFAT Luciferase Reporter Jurkat Cell Line |
78323 |
BPS Bioscience |
2 vials |
EUR 10340 |
Description: Recombinant Jurkat cell line expressing firefly luciferase under the control of an NFAT response element, and with constitutive expression of human TMIGD2 (Transmembrane and immunoglobulin domain containing 2; CD28H; NM_144615). Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
NFAT Luciferase-eGFP Reporter Jurkat Cell Line |
78662 |
BPS Bioscience |
2 vials |
EUR 2195 |
Description: Recombinant Jurkat T cells expressing both firefly luciferase and enhanced GFP (eGFP) under the control of NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway can be monitored by examining either firefly luciferase or eGFP expression. |
ICOS/NFAT Reporter-Jurkat Recombinant Cell Line |
79668 |
BPS Bioscience |
2 vials |
EUR 10340 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of a chimeric receptor consisting human ICOS (also known as inducible T-cell costimulator or CD278, Genbank Accession #NM_012092) and the cytoplasmic domain of human CD3 zeta._x000D_ |
VEGFR2 / NFAT Reporter - HEK293 Recombinant Cell Line |
79387 |
BPS Bioscience |
2 vials |
EUR 12205 |
Description: Recombinant HEK-293 cells expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human VEGFR2 (Human Vascular Endothelial Growth Factor Receptor 2; KDR, FLK1; ref seq. NM_002253.1). |
Human NFAM1/ NFAT activation molecule 1 ELISA Kit |
E1735Hu |
Sunlong |
1 Kit |
EUR 515 |
|
Description: CNAIP,Calcineurin/NFAT-activating ITAM-containing protein,NFAT-activating protein with ITAM motif 1 |
Mouse Nfam1/ NFAT activation molecule 1 ELISA Kit |
E1020Mo |
Sunlong |
1 Kit |
EUR 543 |
|
Description: Cnaip,Calcineurin/NFAT-activating ITAM-containing protein,NFAT-activating protein with ITAM motif 1 |
Mouse Nfam1(NFAT activation molecule 1) ELISA Kit |
EM0772 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.094 ng/ml |
Human NFAT activation molecule 1, NFAM1 ELISA KIT |
ELI-36505h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Mouse NFAT activation molecule 1, Nfam1 ELISA KIT |
ELI-38266m |
Lifescience Market |
96 Tests |
EUR 1038 |
Human NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx520337-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
RK13386 |
Abclonal |
96T |
EUR 280 |
Human NFAT activation molecule 1 (NFAM1) ELISA Kit |
RK11503 |
Abclonal |
96T |
EUR 280 |
Human NFAT activation molecule 1 (Nfam1)ELISA Kit |
SL3395Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Human NFAM1 / NFAT activation molecule 1 ELISA Kit |
E3904h |
EIAab |
96T |
EUR 736 |
Mouse Nfam1 / NFAT activation molecule 1 ELISA Kit |
E3904m |
EIAab |
96T |
EUR 776 |
Human PD-1 / NFAT Reporter Cell Line- Jurkat |
ABC-RC0117 |
AcceGen |
1 vial |
Ask for price |
Description: Human PD-1 / NFAT Reporter Cell Line is derived from Jurkat. Application: • Screen for activators or inhibitors of PD-1 signaling in a cellular context • Characterize the biological activity of PD-1 and its interactions with ligands |
NFAT Luciferase-eGFP Reporter Lentivirus-78656-G |
78656-G |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-eGFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and eGFP cassette driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and a puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or eGFP expression. |
NFAT Luciferase-eGFP Reporter Lentivirus-78656-P |
78656-P |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-eGFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and eGFP cassette driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and a puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or eGFP expression. |
NFAT Reporter - Hek293 Cell Line (PKC/ Ca2+ Pathway) |
79298 |
BPS Bioscience |
2 vials |
EUR 2140 |
Description: The NFAT Reporter - Hek293 cell line contains a firefly luciferase gene under the control of NFAT response element stably integrated into Hek293 cells. This cell line is validated for the response to the stimulation of phorbol 12-myristate 13-acetate (PMA) with ionomycin. |
Human LAG-3 / NFAT Reporter Cell Line-Jurkat |
ABC-RC0102 |
AcceGen |
1 vial |
Ask for price |
Description: Human LAG-3 / NFAT Reporter Cell Line is derived from Jurkat. This reporter cell line can be used to screen for activators or inhibitors of LAG-3 signaling in a cellular context and characterize the biological activity of LAG-3 and its interactions with ligands |
Woodchuck PD-1/NFAT Report Cell Line-Jurkat |
ABC-RC101D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of woodchuck (groundhog, Marmota monax) PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #HQ403652). |
Human NFAT Luciferase Reporter Cell Line- NIH 3T3 |
ABC-RC0025 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Luciferase Reporter Cell Line- NIH 3T3 is derived from mouse fibroblast, and stably express firefly luciferase reporter gene under the control of NFAT response element. This cell line is an ideal cellular model for monitoring the activation of Calcium Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
LAG-3 / NFAT Reporter - Jurkat Recombinant Cell Line |
71278 |
BPS Bioscience |
2 vials |
EUR 11095 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human LAG-3 (lymphocyte-activation gene 3, CD223, GenBank Accession # NM_002286). |
Human NFAT Luciferase Reporter Cell Line- Jurkat T |
ABC-RC0024 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Luciferase Reporter Cell Line- Jurkat T is derived from human T lymphocyte,and stably express firefly luciferase reporter gene under the control of NFAT response element. This cell line is an ideal cellular model for monitoring the activation of Calcium Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line |
78363 |
BPS Bioscience |
2 vials |
EUR 11095 |
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells. Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
TCR Knockout NFAT-Luciferase Reporter Jurkat Cell Line |
78556 |
BPS Bioscience |
2 vials |
EUR 12205 |
Description: This cell line is a knockout of TCR (T Cell Receptor). The TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from recombinant Jurkat cells stably expressing the firefly luciferase gene under the control of NFAT response elements.This cell line has been functionally validated and does not respond to anti-CD3 agonist antibodies, as opposed to parental NFAT-Luciferase Reporter Jurkat cells (BPS Bioscience #60621). |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
20-abx301606 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx235689-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
20-abx217148 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx235689-100g |
Abbexa |
100 µg |
EUR 350 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx301606-100g |
Abbexa |
100 µg |
EUR 362.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx301606-20g |
Abbexa |
20 µg |
EUR 162.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx301606-50g |
Abbexa |
50 µg |
EUR 250 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx375448-96tests |
Abbexa |
96 tests |
EUR 337.5 |
CD160/NFAT - Luciferase Reporter - Jurkat Recombinant Cell Line |
79594 |
BPS Bioscience |
2 vials |
EUR 9400 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human CD160. CD160 is a GPIanchored glycoprotein member of the Ig superfamily, also known as BY55, NK1, and NK28. GenBank Accession # NM_007053._x000D__x000D_ |
LILRB4 NFAT-Luciferase Reporter Jurkat Recombinant Cell Line |
79750 |
BPS Bioscience |
2 vials |
EUR 9870 |
Description: Recombinant Jurkat cells constitutively expressing human LILRB4 (Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 4, GenBank Accession #NM_001278426) and the firefly luciferase gene under the control of NFAT response elements. |
PD-1 (Mouse) / NFAT - Reporter - Jurkat Recombinant Cell Line |
79762 |
BPS Bioscience |
2 vials |
EUR 11095 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of mouse PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_008798). |
Anti-BCMA CAR Jurkat/NFAT (Luciferase) Reporter Cell Line |
79694 |
BPS Bioscience |
2 vials |
EUR 9400 |
Description: The anti-BCMA CAR Jurkat/NFAT-luciferase reporter cell line is a stable cell line made from the anti-BCMA scFV CAR lentivirus (BPS Bioscience #79701). It has been validated for anti BCMA-CAR expression by FACS, and for functional activation stimulated by both soluble BCMA protein (BPS Bioscience #79467) and BCMA/CHO target cells (BPS Bioscience #79500). |
Nfam1 ELISA Kit| Mouse NFAT activation molecule 1 ELISA Kit |
EF013382 |
Lifescience Market |
96 Tests |
EUR 826.8 |
TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line |
78557 |
BPS Bioscience |
2 vials |
EUR 16695 |
Description: This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells to generate the TCR Knockout NFAT Luciferase Reporter Jurkat cell Line (BPS Bioscience #78556). These TCR knockout cells were used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. _x000D_Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
Woodchuck PD-1 / NFAT - Reporter - Jurkat Recombinant Cell Line |
79456 |
BPS Bioscience |
2 vials |
EUR 10340 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of woodchuck (groundhog, Marmota monax) PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #HQ403652)._x000D_ |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (HRP) |
20-abx310130 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (HRP) |
abx310130-100g |
Abbexa |
100 µg |
EUR 362.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (HRP) |
abx310130-20g |
Abbexa |
20 µg |
EUR 162.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (HRP) |
abx310130-50g |
Abbexa |
50 µg |
EUR 250 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (FITC) |
20-abx310131 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (FITC) |
abx310131-100g |
Abbexa |
100 µg |
EUR 362.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (FITC) |
abx310131-20g |
Abbexa |
20 µg |
EUR 162.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (FITC) |
abx310131-50g |
Abbexa |
50 µg |
EUR 250 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (Biotin) |
20-abx310132 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (Biotin) |
abx310132-100g |
Abbexa |
100 µg |
EUR 362.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (Biotin) |
abx310132-20g |
Abbexa |
20 µg |
EUR 162.5 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (Biotin) |
abx310132-50g |
Abbexa |
50 µg |
EUR 250 |
NFAM1 (untagged)-Human NFAT activating protein with ITAM motif 1 (NFAM1) |
SC128119 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Growth Arrested PD-1 / NFAT Reporter - Jurkat Recombinant Cell Line |
79687 |
BPS Bioscience |
2 vials |
EUR 590 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_005018). Note: These cells are unable to complete mitosis and are suitable for single use assays. For cells capable of reproducing, please use our PD-1 / NFAT Reporter - Jurkat Recombinant Cell Line, #60535. |
ADCP Bioassay Effector Cell FcγRIIa (H variant) /NFAT Reporter-Jurkat |
71273 |
BPS Bioscience |
2 vials |
EUR 6875 |
Description: Recombinant Jurkat T cell expressing a firefly luciferase gene under the control of NFAT response elements with constitutive expression of human FcγRIIa, Histidine variant. |
NFAM1 (GFP-tagged) - Human NFAT activating protein with ITAM motif 1 (NFAM1) |
RG207824 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (untagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), (10ug) |
MC211477 |
Origene Technologies GmbH |
10 µg |
Ask for price |
NFAM1 (Myc-DDK-tagged)-Human NFAT activating protein with ITAM motif 1 (NFAM1) |
RC207824 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (GFP-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), (10ug) |
MG220096 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (Myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1) |
MR220096 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (untagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 3 |
MC226337 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (untagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 4 |
MC226338 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (untagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 2 |
MC226426 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (untagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 1 |
MC226671 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Human NFAT activating protein with ITAM motif 1 (NFAM1), mGFP tagged |
RC207824L2 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Human NFAT activating protein with ITAM motif 1 (NFAM1), mGFP tagged |
RC207824L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Nfam1 (mGFP-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1) |
MR220096L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Human NFAT activating protein with ITAM motif 1 (NFAM1), Myc-DDK-tagged |
RC207824L1 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Human NFAT activating protein with ITAM motif 1 (NFAM1), Myc-DDK-tagged |
RC207824L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 3 |
MR228548 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 4 |
MR228549 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 2 |
MR228637 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Nfam1 (myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), transcript variant 1 |
MR228882 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Nfam1 (Myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1) |
MR220096L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3ζ) |
79853 |
BPS Bioscience |
2 vials |
EUR 10340 |
Description: Anti-CD19 CAR/NFAT-luciferase reporter Jurkat cell line is a double stable cell line expressing anti-CD19 CAR and NFAT-luciferase reporter. It is made from the anti-CD19 CAR lentivirus (BPS Bioscience #79851). The reporter cell line has been validated for anti CD19-CAR expression by FACS, and for luciferase reporter activation stimulated by target cells including CD19/CHO recombinant cell line can be used for primary screening and functional validation of anti-CD19 CAR construct and lentivirus before testing in primary T cells.
Anti-CD19 CAR consists of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28, 4-1BB co-stimulatory domains, and CD3ζ signaling domain.
|
Lentiblast-NFAT-GFP |
AX0010024 |
ABM |
1.0 µg DNA |
EUR 245 |
Pwpxl-NFAT-mCh |
AX0010027 |
ABM |
1.0 µg DNA |
EUR 245 |
Lenti ORF particles, NFAM1 (mGFP-tagged) - Human NFAT activating protein with ITAM motif 1 (NFAM1), 200ul, >10^7 TU/mL |
RC207824L2V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, NFAM1 (mGFP-tagged) - Human NFAT activating protein with ITAM motif 1 (NFAM1), 200ul, >10^7 TU/mL |
RC207824L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, Nfam1 (GFP-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), 200ul, >10^7 TU/mL |
MR220096L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, NFAM1 (Myc-DDK tagged) - Human NFAT activating protein with ITAM motif 1 (NFAM1), 200ul, >10^7 TU/mL |
RC207824L1V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, NFAM1 (Myc-DDK tagged) - Human NFAT activating protein with ITAM motif 1 (NFAM1), 200ul, >10^7 TU/mL |
RC207824L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Anti-CD19 CAR negative control/ NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28 transmembrane motif) |
79854 |
BPS Bioscience |
2 vials |
EUR 1650 |
Description: Anti-CD19 CAR negative control/NFAT-luciferase reporter Jurkat cell line is a double stable cell line expressing anti-CD19 CAR negative control and NFAT-luciferase reporter. The anti-CD19 CAR negative control consists of anti-CD19 scFv linked to the CD28 transmembrane motif without any intracellular signaling domains. The reporter cell line has been validated for anti- CD19 expression by FACS, while the stimulation by target cells including CD19/CHO recombinant cell line has not activated the luciferase reporter gene in this cell line. The cell line can be used for the negative control of anti-CD19 CAR/Jurkat-NFAT cell line (BPS Bioscience, #79853)._x000D_ _x000D_ |
Lenti ORF particles, Nfam1 (Myc-DDK-tagged) - Mouse Nfat activating molecule with ITAM motif 1 (Nfam1), 200ul, >10^7 TU/mL |
MR220096L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
pGreenFire1-4x-NFAT (plasmid) |
TR051pa-1 |
SBI |
10 ug |
EUR 720 |
pGreenFire1-4x-NFAT (virus) |
TR051va-1 |
SBI |
>2 x 10^6 IFUs |
EUR 720 |
CD16-NFAT Luciferase Reporter Jurkat Cell Line |
T6504 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
NFATC3 / NFAT4 Peptide |
43-582P |
ProSci |
0.1 mg |
EUR 405.6 |
NFAT2 Antibody / NFATC1 |
RQ5535 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: NFATC1 (Nuclear factor of activated T-cells, cytoplasmic 1), also known as NFATC or NFAT2, is a protein that in humans is encoded by the NFATC1 gene. And it is also a component of the nuclear factor of activated T cells DNA-binding transcription complex. The NFATC1 gene is mapped on 18q23. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. NFATC1 was not detected in brain, liver, or kidney. NFATC1 is an inducible nuclear component which functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. The solution structure of the binary complex formed between the core DNA-binding domain of human NFATC1 and the 12-bp oligonucleotide duplex containing the ARRE2 DNA site from the IL2 promoter. Nfatc1 was expressed exclusively in mouse hair follicle stem cells, and using gain- and loss-of-function approaches, and Nfatc1 inhibited stem cell activation. |
NFAT2 Antibody / NFATC1 |
RQ4810 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
|
Description: 'Nuclear factor of activated T-cells, cytoplasmic 1' plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells. Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function. [UniProt] |
NFAT1 Antibody / NFATC2 |
R32875 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: NFATC2 (Nuclear factor of activated T-cells, cytoplasmic 2), also known as NFATP or the 'preexisting component' of NFAT, is present in the cytosolic fraction of unstimulated T cells, which is also a member of the nuclear factor of activated T cells (NFAT) family. The NFATC2 gene is mapped on 20q13.2. NFATC2 is highly homologous to NFATC1 over a limited domain which shows similarity to the Dorsal/Rel family but has a wider tissue distribution. Ectopic expression of NFATC2 inhibited the basal activity of the human CDK4 promoter. Additionally, both Calna-/- and Nfatc2 -/- mice had elevated protein levels of Cdk4, confirming a negative regulatory role for the calcineurin/NFAT pathway. NFATC2 controls myoblast fusion at a specific stage of myogenesis after the initial formation of a myotube and is necessary for further cell growth. Overexpression of NFATC2 promoted differentiation of osteoclast precursor cells into tartrate-resistant acid phosphatase-positive (TRAP-positive) multinucleated osteoclast-like cells even in the absence of RANKL. |
NFATC3 Antibody / NFAT4 |
R32932 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: Nuclear factor of activated T-cells, cytoplasmic 3 is a protein that in humans is encoded by the NFATC3 gene. The product of this gene is a member of the nuclear factors of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation and an inducible nuclear component. Other members of this family participate to form this complex also. The product of this gene plays a role in the regulation of gene expression in T cells and immature thymocytes. |
NFAT2 Antibody / NFATC1 (isoforms A/B/C) |
R32829 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: NFATC1 (Nuclear factor of activated T-cells, cytoplasmic 1), also known as NFATC or NFAT2, is a protein that in humans is encoded by the NFATC1 gene. And it is also a component of the nuclear factor of activated T cells DNA-binding transcription complex. The NFATC1 gene is mapped on 18q23. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. NFATC1 was not detected in brain, liver, or kidney. NFATC1 is an inducible nuclear component which functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. The solution structure of the binary complex formed between the core DNA-binding domain of human NFATC1 and the 12-bp oligonucleotide duplex containing the ARRE2 DNA site from the IL2 promoter. Nfatc1 was expressed exclusively in mouse hair follicle stem cells, and using gain- and loss-of-function approaches, and Nfatc1 inhibited stem cell activation. |
T-Cell Transcription Factor NFAT3 (NFAT3) Antibody |
20-abx217154 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
T-Cell Transcription Factor NFAT3 (NFAT3) Antibody |
20-abx133256 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
T-Cell Transcription Factor NFAT3 (NFAT3) Antibody |
20-abx133257 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
T-Cell Transcription Factor NFAT4 (NFAT4) Antibody |
abx011684-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
NFAT1 |
E8ET1704-14 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
NFAT2 |
E8ET1704-45 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
NFAT5 |
CSB-CL015744HU |
Cusabio |
10 μg plasmid + 200μl Glycerol |
Ask for price |
Nfat5 (untagged ORF) - Rat nuclear factor of activated T-cells 5 (Nfat5), (10 ug) |
RN208725 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Polyclonal NFAT1 / NFATC2 Antibody (Internal) |
APR08726G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NFAT1 / NFATC2 (Internal). This antibody is tested and proven to work in the following applications: |
NFAT5 siRNA |
20-abx925796 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NFAT5 siRNA |
20-abx925797 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NFAT5 siRNA |
20-abx903542 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Nfat5 (Myc-DDK-tagged ORF) - Rat nuclear factor of activated T-cells 5 (Nfat5), (10 ug) |
RR208725 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Polyclonal NFATC4 / NFAT3 Antibody (internal region) |
APR17551G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NFATC4 / NFAT3 (internal region). This antibody is tested and proven to work in the following applications: |
Polyclonal NFATC2 / NFAT1 Antibody (internal region) |
APR08728G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NFATC2 / NFAT1 (internal region). This antibody is tested and proven to work in the following applications: |
NFAT1 Rabbit pAb |
E2381764 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Consistently higher staining high quality was noticed in slides stained by RabMAb vs MMAb. RabMAb and MMAb towards E-cadherin have been diagnostically equal aside from one case the place RabMAb might have led to diagnostic misinterpretation.
However, the not insignificant value financial savings and simpler interpretation utilizing RabMAb might justify the chance of misinterpretation of elevated staining in uncommon instances, largely avertable with correct coaching.